This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Clovis Oncology Gestione
Gestione criteri di controllo 3/4
Clovis Oncology's CEO is Patrick Mahaffy, appointed in Apr 2009, he has a tenure of 14.25 years. He directly owns 0.67% of the company’s shares, worth €14.56K. The average tenure of the management team and the board of directors is 7.4 years and 14.3 years respectively.`
Informazioni chiave
Patrick Mahaffy
Amministratore delegato
n/a
Compenso totale
Percentuale dello stipendio del CEO | n/a |
Mandato del CEO | 14.3yrs |
Proprietà del CEO | 0.7% |
Durata media del management | 7.4yrs |
Durata media del Consiglio di amministrazione | 14.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$252m |
Jun 30 2022 | n/a | n/a | -US$263m |
Mar 31 2022 | n/a | n/a | -US$258m |
Dec 31 2021 | US$3m | US$739k | -US$265m |
Sep 30 2021 | n/a | n/a | -US$299m |
Jun 30 2021 | n/a | n/a | -US$310m |
Mar 31 2021 | n/a | n/a | -US$336m |
Dec 31 2020 | US$3m | US$721k | -US$369m |
Sep 30 2020 | n/a | n/a | -US$370m |
Jun 30 2020 | n/a | n/a | -US$385m |
Mar 31 2020 | n/a | n/a | -US$413m |
Dec 31 2019 | US$7m | US$719k | -US$400m |
Sep 30 2019 | n/a | n/a | -US$400m |
Jun 30 2019 | n/a | n/a | -US$396m |
Mar 31 2019 | n/a | n/a | -US$377m |
Dec 31 2018 | US$6m | US$689k | -US$368m |
Sep 30 2018 | n/a | n/a | -US$321m |
Jun 30 2018 | n/a | n/a | -US$291m |
Mar 31 2018 | n/a | n/a | -US$366m |
Dec 31 2017 | US$9m | US$636k | -US$346m |
Sep 30 2017 | n/a | n/a | -US$365m |
Jun 30 2017 | n/a | n/a | -US$370m |
Mar 31 2017 | n/a | n/a | -US$324m |
Dec 31 2016 | US$789k | US$224k | -US$349m |
Compensazione vs Mercato: Insufficient data to establish whether Patrick's total compensation is reasonable compared to companies of similar size in the German market.
Compensazione vs guadagni: Patrick's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Patrick Mahaffy (60 yo)
14.3yrs
Mandato
US$2,639,083
Compensazione
Mr. Patrick J. Mahaffy, M.A., co-founded Clovis Oncology, Inc. in April 20, 2009 and has been its Chief Executive Officer and President since April 20, 2009. Mr. Mahaffy served as the Chief Executive Offic...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | 14.3yrs | US$2.64m | 0.67% € 14.6k | |
Executive VP & CFO | 7.3yrs | US$1.19m | 0.072% € 1.6k | |
Executive VP | 7.5yrs | US$1.20m | 0.068% € 1.5k | |
Executive VP of Clinical Development & Pharmacovigilance and Chief Medical Officer | 7.9yrs | US$1.24m | 0.078% € 1.7k | |
Executive VP & Chief Scientific Officer | 3.8yrs | Nessun dato | Nessun dato | |
Executive Vice President of Human Resources | 6.8yrs | Nessun dato | Nessun dato |
7.4yrs
Durata media
58yo
Età media
Gestione esperta: C6O's management team is seasoned and experienced (7.4 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | 14.3yrs | US$2.64m | 0.67% € 14.6k | |
Independent Director | 14.3yrs | US$260.00k | 0.041% € 889.9 | |
Independent Director | 14.5yrs | US$270.00k | 0.040% € 875.1 | |
Independent Director | 14.5yrs | US$270.00k | 0.17% € 3.8k | |
Independent Director | 14.5yrs | US$270.00k | 0.044% € 953.2 | |
Independent Chairman | 10.5yrs | US$287.50k | 0% € 0 | |
Independent Director | 14.5yrs | US$257.50k | 0.040% € 872.7 | |
Director | 2yrs | US$375.21k | Nessun dato | |
Independent Director | 10.5yrs | US$259.58k | 0% € 0 | |
Independent Director | 4.8yrs | US$257.50k | 0% € 0 | |
Independent Director | 4.8yrs | US$255.00k | 0% € 0 |
14.3yrs
Durata media
67yo
Età media
Consiglio di amministrazione esperto: C6O's board of directors are seasoned and experienced ( 14.3 years average tenure).